Perioperative management of acquired von Willebrand disease in cardiac surgery: type 2B or not 2B?
Sardesai
Mahesh P
MP
Department of Cardiothoracic Anesthesiology, Cleveland Clinic, Cleveland, OH 44195, USA.
Sabik
Joseph
J
Koch
Colleen G
CG
D000925:Anticoagulants / Q000627:therapeutic use; D001011:Aorta / Q000473:pathology; D001021:Aortic Valve / Q000601:surgery; D001022:Aortic Valve Insufficiency / Q000473:pathology / Q000601:surgery; D006348:Cardiac Surgical Procedures / Q000379:methods*; D015944:Factor VIIIa / Q000627:therapeutic use; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D019990:Perioperative Care / Q000379:methods*; D011182:Postoperative Care; D011300:Preoperative Care; D013927:Thrombosis / Q000209:etiology; D014859:Warfarin / Q000627:therapeutic use; D056728:von Willebrand Disease, Type 2 / Q000145:classification / Q000188:drug therapy / Q000628:therapy*
D000925:Anticoagulants; D014859:Warfarin; D015944:Factor VIIIa